# Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression

> **NCT02742064** · — · COMPLETED · sponsor: **Cogito Health Inc** · enrollment: 899 (actual)

## Conditions studied

- Depression
- Bipolar Disorder

## Interventions

- **OTHER:** Cogito Companion Mobile Phone Application

## Key facts

- **NCT ID:** NCT02742064
- **Lead sponsor:** Cogito Health Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-03-31
- **Target enrollment:** 899 (ACTUAL)
- **Last updated:** 2018-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02742064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02742064, "Quantified Mobile Sensing for Improving Diagnosis and Measuring Disease Progression". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02742064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*